SPQ MALB CONTROL LEVEL II— 510(k) K934521

Name: FDA 510(k) clearance K934521
Creator: U.S. Food and Drug Administration
Published: 1993-11-26

Substantially Equivalent

Incstar Corp.

FDA 510(k) clearance K934521 for SPQ MALB CONTROL LEVEL II, Substantially Equivalent on 1993-11-26. Applicant: Incstar Corp.. Device class: 1.

Clearance details

Applicant: Incstar Corp.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1993-09-17
Decision date: 1993-11-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Incstar Corp.

view all

K963289 — INCSTAR TOXOPLASMA IGM CAPTURE ELISA ASSAY1997-05-01
K963296 — INCSTAR TOXOPLASMA IGG ALISA ASSAY (CAT.#7565)1996-12-16
K963297 — INCSTAR TOXOPLASMA IGG FAST ELISA ASSAY (CAT.#7560)1996-12-16
K960358 — INCSTAR RUBELLA IGG FAST ELISA ASSAY1996-10-24
K960367 — INCSTAR RUBELLA IGG ELISA ASSAY1996-10-24

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.